1mzc

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1mzc.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1mzc.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1mzc| PDB=1mzc | SCENE= }}
{{STRUCTURE_1mzc| PDB=1mzc | SCENE= }}
-
'''Co-Crystal Structure Of Human Farnesyltransferase With Farnesyldiphosphate and Inhibitor Compound 33a'''
+
===Co-Crystal Structure Of Human Farnesyltransferase With Farnesyldiphosphate and Inhibitor Compound 33a===
-
==Overview==
+
<!--
-
A series of novel diaryl ether lactams have been identified as very potent dual inhibitors of protein farnesyltransferase (FTase) and protein geranylgeranyltransferase I (GGTase-I), enzymes involved in the prenylation of Ras. The structure of the complex formed between one of these compounds and FTase has been determined by X-ray crystallography. These compounds are the first reported to inhibit the prenylation of the important oncogene Ki-Ras4B in vivo. Unfortunately, doses sufficient to achieve this endpoint were rapidly lethal.
+
The line below this paragraph, {{ABSTRACT_PUBMED_12825937}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 12825937 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_12825937}}
==About this Structure==
==About this Structure==
Line 46: Line 50:
[[Category: Pftase]]
[[Category: Pftase]]
[[Category: Ra]]
[[Category: Ra]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 01:53:39 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 17:47:08 2008''

Revision as of 14:47, 28 July 2008

Template:STRUCTURE 1mzc

Co-Crystal Structure Of Human Farnesyltransferase With Farnesyldiphosphate and Inhibitor Compound 33a

Template:ABSTRACT PUBMED 12825937

About this Structure

1MZC is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents., deSolms SJ, Ciccarone TM, MacTough SC, Shaw AW, Buser CA, Ellis-Hutchings M, Fernandes C, Hamilton KA, Huber HE, Kohl NE, Lobell RB, Robinson RG, Tsou NN, Walsh ES, Graham SL, Beese LS, Taylor JS, J Med Chem. 2003 Jul 3;46(14):2973-84. PMID:12825937

Page seeded by OCA on Mon Jul 28 17:47:08 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools